EUVIMEDEUVIMED entdecken
Crossref

HLA Evolutionary Divergence and Paediatric Disease Risk: Unveiling Genetic Associations

Donato Madalese iD, Laura Auriemma, Martina Esposito, Mario Toriello, Stefania Nappo, Stefania Lama, Francesco Topo, Lucia Gallo, Giovanni Castellano, Natasha Martino, Rosa Colucci, Roberto Crocchiolo iD und 2 weitere

HLA · 2026-04 · 107 (4)

DOI: 10.1111/tan.70721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, online erschienen am 24.04.2026. Verfasst von Donato Madalese und 13 weiteren Autor:innen. Beteiligte Einrichtung: UOSD Ba.S.C.O., Manipolazione Cellulare ed Immunogenetica - Department of Oncology Haematology and Cell Therapies, AORN Santobono-Pausilipon, Naples,…. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, HLA Antigens, Evolution, Molecular. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The HLA system plays a crucial role in immune recognition, with genetic variability influencing disease susceptibility. This study examines the association between HLA evolutionary divergence (HED) scores and paediatric haematological malignancies, aiming to determine whether locus‐specific HED profiles correlate with disease risk. A cohort of 89 paediatric patients (age ≤ 20) with high‐resolution HLA typing (A, B, C loci) was analysed. HED scores were categorised into eight distinct profiles (H = High, L = Low divergence). Statistical associations were assessed using Fisher's exact test and binary logistic regression to adjust for potential confounders, including age and sex. The LHH profile (low divergence at Locus A, high at B and C) emerged as a significant risk factor for Acute Lymphoblastic Leukaemia (ALL), showing a three‐fold increase in risk (OR = 3.24; p = 0.0481). Conversely, high divergence at Locus B alone showed a trend toward ALL susceptibility (OR = 2.17; p = 0.056). Multivariable regression confirmed that HED is an independent biological variable, with no significant influence from age ( p = 0.689) or sex ( p = 0.756). Furthermore, HED profiles significantly influenced the age at diagnosis (clinical latency); for instance, patients with the HHL profile exhibited a delayed onset compared to HHH profiles (mean age 12.47 vs. 6.58 years), suggesting that specific HED configurations may modulate the kinetics of immune evasion. These findings demonstrate that HED, particularly at the HLA‐A locus, is a critical determinant of leukaemia susceptibility. The identification of the HLA‐A ‘bottleneck’ (LHH profile) suggests a selective failure in antigen presentation, potentially leading to compromised anti‐tumour surveillance. The independence of HED from standard clinical variables and its impact on disease latency highlight its potential as a robust immunogenetic biomarker for risk stratification and personalised monitoring in paediatric oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensEvolution, MolecularHumansFemaleChildMaleChild, PreschoolAdolescentRisk FactorsInfantHistocompatibility Testing

Stichwörter der Autor:innen

ALLAMLHEDHLAPaediatric haematological diseaseevolutionary divergenceimmunogenetics

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • UOSD Ba.S.C.O., Manipolazione Cellulare ed Immunogenetica - Department of Oncology Haematology and Cell Therapies, AORN Santobono-Pausilipon, Naples, Italy.
  • Stem Cell Transplantation and Cell Therapy Unit, Department of Oncology Haematology and Cell Therapies, AORN Santobono-Pausilipon, Naples, Italy.
  • Servizio Immunotrasfusionale, Ospedale Madonna delle Grazie - ASM Matera, Matera, Italy.
  • Immunohematology and Transfusion Medicine Service, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.

ORCID-Profile: Donato Madalese, Roberto Crocchiolo

Zitieren

APA

Madalese, D., Auriemma, L., Esposito, M., Toriello, M., Nappo, S., Lama, S., Topo, F., Gallo, L., Castellano, G., Martino, N., Colucci, R., Crocchiolo, R., Tambaro, F. P., & Penta de Vera d'Aragona, R. (2026). HLA Evolutionary Divergence and Paediatric Disease Risk: Unveiling Genetic Associations. HLA, 107(4). https://doi.org/10.1111/tan.70721

Vancouver

Madalese D, Auriemma L, Esposito M, Toriello M, Nappo S, Lama S, et al. HLA Evolutionary Divergence and Paediatric Disease Risk: Unveiling Genetic Associations. HLA. 2026;107(4). doi:10.1111/tan.70721

BibTeX
@article{Madalese2026,
  author = {Madalese, Donato and Auriemma, Laura and Esposito, Martina and Toriello, Mario and Nappo, Stefania and Lama, Stefania and Topo, Francesco and Gallo, Lucia and Castellano, Giovanni and Martino, Natasha and Colucci, Rosa and Crocchiolo, Roberto and Tambaro, Francesco Paolo and Penta de Vera d'Aragona, Roberta},
  title = {HLA Evolutionary Divergence and Paediatric Disease Risk: Unveiling Genetic Associations},
  journal = {HLA},
  year = {2026},
  volume = {107},
  number = {4},
  doi = {10.1111/tan.70721}
}
Kostenlos starten →